Schrodinger, Inc. (SDGR) KPIs and segments
Close on Nov 12, 2026Market cap $2.31BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Schrodinger's business
Schrodinger's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Software($M) | 35.5 | 35.6 | 69.3 | 40.9 | 40.5 | 48.8 | 79.7 | 31.9 | 35.4 | 33.4 | 68.7 | 28.9 | |
Drug Discovery($M) | 23.4 | 23.0 | 18.0 | 13.5 | 14.2 | 10.7 | 8.66 | 3.41 | 11.9 | 3.18 | 5.47 | 13.7 | |
Revenue from contracts with customers($M) | 35.9 | 36.0 | 45.0 | 28.8 | 35.4 | 33.4 | 27.1 | ||||||
Software products and services($M) | 32.5 | 35.6 | 69.3 | 40.9 | 36.0 | 45.0 | 79.7 | 31.9 | 35.4 | 33.4 | 68.7 | 28.9 | |
Drug discovery($M) | 23.0 | 22.9 | 18.0 | 13.5 | 13.9 | 10.2 | 8.66 | 3.41 | 11.9 | 3.18 | 5.47 | 13.7 | |
Hosted software($M) | 15.2 | 12.1 | 11.5 | 11.6 | 11.1 | 10.9 | 11.2 | 8.81 | 8.09 | 7.18 | 6.02 | 5.46 | |
On-premise software($M) | 9.30 | 14.2 | 44.4 | 15.9 | 15.7 | 25.4 | 55.4 | 12.3 | 18.8 | 17.6 | 53.9 | 13.8 | |
Software maintenance($M) | 4.88 | 6.66 | 6.89 | 6.83 | 6.78 | 6.80 | 5.89 | 5.66 | 5.84 | 5.90 | 5.69 | 5.75 | |
Contribution($M) | 3.36 | 0.15 | 4.79 | 4.34 | 3.12 | 0 | 0 | 1.80 | |||||
Professional services($M) | 3.22 | 2.64 | 3.80 | 1.59 | 2.38 | 1.88 | 2.32 | 2.04 | 2.72 | 2.73 | 3.01 | 2.08 | |
Software contribution($M) | 2.92 | 0 | 17.6 | 13.0 | 4.51 | 3.84 | 8.13 | 2.81 | 11.5 | 2.69 | |||
Drug discovery contribution($M) | 0.44 | 0.15 | 0.28 | 0.50 | |||||||||
United States($M) | 37.5 | 31.4 | 57.9 | 31.3 | 34.1 | 29.7 | 36.3 | 24.6 | 30.7 | 23.3 | 54.5 | 33.1 | |
APAC($M) | 14.4 | 20.2 | 22.8 | 15.7 | 13.6 | 23.1 | 45.5 | 5.15 | 8.71 | 7.20 | 13.7 | 3.76 | |
EMEA($M) | 6.70 | 6.67 | 6.38 | 6.76 | 6.97 | 6.07 | 6.31 | 5.28 | 7.81 | 5.50 | 5.69 | 5.57 | |
Rest of World($M) | 0.29 | 0.33 | 0.14 | 0.52 | 0.18 | 0.73 | 0.25 | 0.24 | 0.12 | 0.60 | 0.19 | 0.12 | |
Software($M) | 24.9 | 23.3 | 55.9 | 29.7 | 27.5 | 35.3 | 66.4 | 23.4 | 28.2 | 25.4 | 60.0 | 21.9 | |
Drug Discovery($M) | 7.51 | 6.29 | 1.35 | -1.71 | -1.36 | -4.17 | -2.25 | -5.68 | 3.10 | -6.55 | -2.44 | 1.77 | |
Software products and services($M) | 23.1 | 24.7 | 55.9 | 29.7 | 27.2 | 35.9 | 66.4 | 23.4 | 28.2 | 25.4 | 60.0 | 21.9 | |
Drug discovery($M) | 7.19 | 6.57 | 1.35 | -1.71 | -1.20 | -4.22 | -2.25 | -5.68 | 3.10 | -6.55 | -2.44 | 1.77 | |
Contribution($M) | 2.15 | -1.72 | 0.11 | -0.52 | |||||||||
Remaining performance obligations (RPO)($M) | 189 | 211 | 240 | 53.2 | 56.2 | 62.7 | 40.0 | 41.7 | 32.0 | 18.7 | |||
2 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-05.
See a number that looks wrong?